Brief: Secure Trial Update First Patient Treated In The Phase Ii Cohort Expansion
15/04/2025 14:37
April 15 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX: SECURE TRIAL UPDATE: FIRST PATIENT TREATED IN THE PHASE II COHORT EXPANSION Source text: ID:nPn3vgRSNa Further company coverage: CU6.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial